Cargando…
Development of Novel Class of Phenylpyrazolo[3,4-d]pyrimidine-Based Analogs with Potent Anticancer Activity and Multitarget Enzyme Inhibition Supported by Docking Studies
Phenylpyrazolo[3,4-d]pyrimidine is considered a milestone scaffold known to possess various biological activities such as antiparasitic, antifungal, antimicrobial, and antiproliferative activities. In addition, the urgent need for selective and potent novel anticancer agents represents a major route...
Autores principales: | Aljohani, Ahmed K. B., El Zaloa, Waheed Ali Zaki, Alswah, Mohamed, Seleem, Mohamed A., Elsebaei, Mohamed M., Bayoumi, Ashraf H., El-Morsy, Ahmed M., Almaghrabi, Mohammed, Awaji, Aeshah A., Hammad, Ali, Alsulaimany, Marwa, Ahmed, Hany E. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573254/ https://www.ncbi.nlm.nih.gov/pubmed/37834474 http://dx.doi.org/10.3390/ijms241915026 |
Ejemplares similares
-
Design, Synthesis, In Vitro, and In Silico Studies of New N(5)-Substituted-pyrazolo[3,4-d]pyrimidinone Derivatives as Anticancer CDK2 Inhibitors
por: Zaki, Waheed A., et al.
Publicado: (2023) -
7-Chloro-5-methyl-2-phenylpyrazolo[1,5-a]pyrimidine
por: Bassoude, Ibtissam, et al.
Publicado: (2013) -
Ethyl 7-methyl-2-phenylpyrazolo[1,5-a]pyrimidine-5-carboxylate
por: Bassoude, Ibtissam, et al.
Publicado: (2013) -
Synthesis and Biological Evaluation of Some [1,2,4]Triazolo[4,3-a]quinoxaline Derivatives as Novel Anticonvulsant Agents
por: Alswah, Mohamed, et al.
Publicado: (2013) -
Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects
por: Alswah, Mohamed, et al.
Publicado: (2017)